Holen Sie sich die Stockscreener-App
10.82
0.09%
0.02
Finanzdaten der Kalvista Pharmaceuticals Inc-Aktie (KALV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
28.16%
55.03
|
42.94 | 45.81 | 44.22 | 48.45 |
| Operating Income/Loss |
28.16%
-55.03
|
-42.94 | -45.81 | -44.22 | -48.45 |
| Nonoperating Income/Loss |
247.43%
1.949
|
-1.322 | 3.543 | 3.772 | 3.806 |
| Income/Loss From Continuing Operations Before Tax |
19.92%
-53.08
|
-44.26 | -42.27 | -40.44 | -44.65 |
| Income Tax Expense/Benefit |
120.13%
-0.855
|
4.247 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
7.66%
-52.23
|
-48.51 | -42.27 | -40.44 | -44.65 |
|
Net Income/Loss
|
7.66%
-52.23
|
-48.51 | -42.27 | -40.44 | -44.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.85%
1.1305
|
52.64 | 46.70 | 46.23 | 2.2187 |
| Diluted Average Shares |
97.85%
1.1305
|
52.64 | 46.70 | 46.23 | 2.2187 |
| Basic Earnings Per Share |
7.61%
-0.99
|
-0.92 | -0.91 | -0.87 | -1.07 |
| Diluted Earnings Per Share |
7.61%
-0.99
|
-0.92 | -0.91 | -0.87 | -1.07 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.09%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):